MassBiologics

Form 483 issued May 24, 2012 · Boston, Massachusetts

Inspection
May 16 – May 24, 2012
Observations
5
Pages
3
FEI number
3003058218

In short: On May 24, 2012, FDA issued a Form 483 with 5 observations to MassBiologics in Boston, Massachusetts (FEI 3003058218) after an inspection that ran May 16 – May 24, 2012. The investigators were James Keller, Leslie Wagner and Susan M. Jackson. Most observations concern production and quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

Production and quality system account for 3 of 5 observations.

Production2
Quality system1
Other2

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Observation 1: scanned text, readable in the full document.

  2. 02

    The root cause assigned to Deviation ID-09-126…

  3. 03

    Deviation…

  4. 04

    There is no written procedure requiring that all filling operators work in the aseptic operation of…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at MassBiologics?

FDA listed 5 observations on this Form 483, mostly about production and quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected MassBiologics?

James Keller, Leslie Wagner and Susan M. Jackson are named on this Form 483, for the inspection of May 16 – May 24, 2012. Each investigator has a profile showing what they cite most.

When was MassBiologics inspected by FDA?

The inspection ran May 16 – May 24, 2012, and the Form 483 is dated May 24, 2012.

How do I get the full Form 483 for MassBiologics?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free